Eisai
4523.T
#2301
Rank
HK$64.08 B
Marketcap
HK$227.17
Share price
2.66%
Change (1 day)
3.56%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.77. an increase over its 2024 EPS that were of HK$7.63.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5411.85%
2024HK$7.63-32.63%
2023HK$11.335.52%
2022HK$10.73-74.01%
2021HK$41.30-66.58%
2020HK$123.5698.24%
2019HK$62.3317.01%
2018HK$53.2737.78%
2017HK$38.66-27.62%
2016HK$53.4235.33%
2015HK$39.47-2.82%
2014HK$40.62-27.66%
2013HK$56.15-27.49%
2012HK$77.44-12.67%
2011HK$88.6888.08%
2010HK$47.15-11.06%
2009HK$53.02-390.15%
2008-HK$18.27-127.78%
2007HK$65.7811.78%
2006HK$58.854.38%
2005HK$56.387.4%
2004HK$52.5043.03%
2003HK$36.7125.09%
2002HK$29.3452.67%
2001HK$19.2269.76%
2000HK$11.32